Gsk Share Discussion Threads

[tradermichael] 12/3/2020 10:30

This is the thing with 'all in one basket' versus a 'diverse portfolio', at times like this the market is driven by fear and panic. Most, if not all stocks are affected by massive falls, no matter what sector.

Holding a single company (like GSK) is sometimes more safe for the recovery if you have a defensive stock. In a diverse portfolio, a proportion of the shares will recover in line with the market (or better) while others can get left behind. That takes some clever management to get back to performance.

[tradermichael] 12/3/2020 10:22

I'm all-in with GSK, no spare cash (till the next dividend payout). I missed the opportunity to sell near the top and once corona took over wasn't prepared to sell on the way down and re-purchase as per normal. So, waiting for the recovery!

In a way, a good thing because the price fall has been relentless, and I would have re-entered at a far too high a price (in hindsight).

[porsche1945] 12/3/2020 10:08

Back in at 1447 to start building a position, I love this share, one of the best for trading I have ever owned, will be serious money to be made on the bounce, the whole thing over hyped and juiced by social media, will soon get boring and markets in general and Gsk in particular will bounce. Its times like this you make real money, as long as you have the funds or Lombard margin.

[daveboy1] 12/3/2020 09:59

Hi Michael. Yes, my diverse portfolio is looking like a united mess! Hope it picks up for you in the near future, when all this madness is a (hopefully) distant memory.
May I ask, are you just GSK, or others as well?

[essentialinvestor] 12/3/2020 09:59

MJ, thought you usually nipped in and out with your GSK holding?.

[tradermichael] 12/3/2020 09:57

Good luck to you! Meanwhile, I'm getting murdered! (Still, there's always the dividend LOL)

[daveboy1] 12/3/2020 09:52

Good morning fellow investors. I'm back in today at my old 2017 levels once again. Crazy price in a crazy world. Good luck to all holders.

[stevieweebie2] 12/3/2020 08:55

Porsche , your a real nice guy, I bet your kids just dote on you dont they, filtered..

[porsche1945] 11/3/2020 20:28

Oh and of course the uk in such a good place, trashed currency, zero growth, medieval productivity and a credit junkie population about to pay the price, get real morons. And the South now having to subsidise the hopeless north even more.

[chessman2] 11/3/2020 12:33

Porsche is now on my filtered list as some posters just cannot move on.

It will be interesting to see how Italy escapes from their economic problems after the corona virus issues. Such problems could well mean an EU collapse as Europe is now weak financially.

In the meantime I believe GSK to be a long term hold for both the divi and capital growth.

[porsche1945] 11/3/2020 11:40

FYI no sensible countries EVER have referendums, and now you can see why. Most people are too thick to be allowed to vote on anything much let alone a 45 year old trade agreement with the largest trading block in the world that the UK helped build. The trouble is with allowing morons to vote is there are alot of them and they tend to have little to lose.

[essentialinvestor] 11/3/2020 11:39

Lol, I sold at 1550 on the opening bell.

This is not my favoured strategy.

[porsche1945] 11/3/2020 11:36

@ croosingtherubicon

Haha, the usual “ intelligent “ response from knuckle dragging “ gammons “ brexit morons. (Self harmers) Such a shame the great unwashed like you were allowed to drag down the rest of us, the economy and sterling.

[badtime] 10/3/2020 17:58

Welcome...will you be staying longer than a day? :)

[essentialinvestor] 10/3/2020 17:50

Back in today for the first time in a while. Ugly markets atm! - understatement.

[tradermichael] 10/3/2020 15:37

Agenus Inc. on Tuesday reported the triggering of a $15.1 million milestone payment from HealthCare Royalty Partners based on sales of GlaxoSmithKline's Shingrix vaccine exceeding $2 billion in 2019.
Agenus said its proprietary QS-21 Stimulon is a key component in GlaxoSmithKline's Shingrix vaccine, which has generated sales exceeding $2.3 billion in its second year after launch.
Agenus said it is due another milestone amounting to $25.5 million if Shingrix sales exceed $2.75 billion over four consecutive quarters before 2026.

[nimbo1] 10/3/2020 15:00

GSK if you are going back to £13 please do it quickly so I can buy some.

[alphorn] 10/3/2020 13:54

TM - good news for sufferers. A little snippet on the early HIV treatment - as with all new drugs there is a discussion on presentation (eg tablet shape and colour) to patients prior to final approval. There was a push for some quite smart presentation and particularly colours until someone said that if you were an HIV patient you would not want to draw attention to the drug that you were taking.

[tradermichael] 10/3/2020 12:55

Kimberly Smith, head of Research & Development at ViiV, said: "We now have positive data showing the effectiveness and safety of a long-acting HIV treatment that is administered every two months. We also have patient preference data showing that study participants overwhelmingly preferred both the monthly and every-two-month long-acting regimens, over oral treatment. This two-drug regimen may provide an opportunity for people living with HIV who take daily medication to reduce their total treatment dosing days from 365 a year to six."

[tradermichael] 09/3/2020 14:50

Over 15m shares traded today - big volume so far

[rikky72] 08/3/2020 18:15

Dr B - Not only full of bluster but an unpleasant individual as well. Good advice - filtered herewith!